Ethacrynic Acid Exhibits Selective Toxicity to Chronic Lymphocytic Leukemia Cells by Inhibition of the Wnt/β-Catenin Pathway
Desheng Lu, Jerry X. Liu, Tomoyuki Endo et al. · 2009
Read Ethacrynic Acid Exhibits Selective Toxicity to Chronic Lymphocytic Leukemia Cells by Inhibition of the Wnt/β-Catenin Pathway by Desheng Lu, Jerry X. Liu, Tomoyuki Endo et al. (2009) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0008294.txt.
Description
Desheng Lu, Jerry X. Liu, and Tomoyuki Endo tested a drug on leukemia cells in PLOS ONE in 2009. Abnormal activation of Wnt/beta-catenin signaling promotes several cancers. That pathway is switched on in chronic lymphocytic leukemia cells. Uncontrolled signaling may contribute to the defect in apoptosis, the death of faulty cells. The team studied ethacrynic acid, an existing drug.
Ethacrynic acid showed selective toxicity to the leukemia cells. It acted by inhibiting the Wnt/beta-catenin pathway. Selectivity matters, because a useful drug must spare healthy cells. The result suggests a new use for an old drug.
Catalog record
| CREATOR | Desheng Lu, Jerry X. Liu, Tomoyuki Endo et al. |
|---|---|
| YEAR | 2009 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 44 KB |
| LICENSE | Creative Commons Attribution License |
| RIGHTS | CC BY |
| SOURCE | PLOS ONE |
Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0008294